Dermapharm Holding SE Net Asset Quality Index
Dermapharm Holding SE net asset quality index. Dermapharm Holding SE (DMP) has a Net Asset Quality Index of 32.3% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €2.27 Billion minus total liabilities of €1.54 Billion yields net assets of €735.17 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Dermapharm Holding SE (DMP) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Dermapharm Holding SE (2013–2025)
Net asset quality index of Dermapharm Holding SE from 2013 to 2025. This chart shows how Dermapharm Holding SE's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the index stands at 32.3%, representing net assets of €735.17 Million against total assets of €2.27 Billion EUR. See Dermapharm Holding SE net assets for net asset value and shareholders' equity analysis.
Dermapharm Holding SE Net Asset Quality Index by Year (2013–2025)
Dermapharm Holding SE net asset quality index by year from 2013 to 2025. The table below presents the year-by-year Net Asset Quality Index for Dermapharm Holding SE from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see DMP stock market capitalisation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 31.8% | €701.83 Million | €2.20 Billion | €1.50 Billion | ▲ +2.6 pp |
| 2024 | 29.2% | €608.29 Million | €2.08 Billion | €1.47 Billion | ▲ +4.0 pp |
| 2023 | 25.2% | €545.05 Million | €2.16 Billion | €1.62 Billion | ▼ -12.5 pp |
| 2022 | 37.7% | €532.49 Million | €1.41 Billion | €880.34 Million | ▲ +2.2 pp |
| 2021 | 35.5% | €499.83 Million | €1.41 Billion | €907.13 Million | ▲ +9.0 pp |
| 2020 | 26.5% | €324.58 Million | €1.22 Billion | €899.81 Million | ▼ -0.7 pp |
| 2019 | 27.2% | €284.49 Million | €1.04 Billion | €760.38 Million | ▼ -9.1 pp |
| 2018 | 36.3% | €256.08 Million | €704.58 Million | €448.50 Million | ▲ +18.6 pp |
| 2017 | 17.7% | €73.69 Million | €415.30 Million | €341.62 Million | ▼ -1.8 pp |
| 2016 | 19.5% | €60.81 Million | €311.70 Million | €250.89 Million | ▲ +4.5 pp |
| 2015 | 15.0% | €44.44 Million | €296.67 Million | €252.22 Million | ▲ +4.7 pp |
| 2014 | 10.3% | €34.01 Million | €330.60 Million | €296.59 Million | ▼ -1.5 pp |
| 2013 | 11.8% | €41.36 Million | €349.98 Million | €308.62 Million | — |